Modulating key inflammatory mediators, including NF-κB, STAT3, and PI3K, may help reduce the tumor-promoting effects of neutrophils while preserving or amplifying their tumor-fighting functions[11]. The gene discussed is NFKB1; the disease is neoplasm.